Compare Alcon AG (ALC) vs Commvault Systems Inc (CVLT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs Commvault Systems Inc — how do they compare? Alcon AG trades at $66.95 (market cap $32.69B), while Commvault Systems Inc trades at $147.98 (market cap $6.37B). The key difference: Alcon AG is far larger — about 5.1× Commvault Systems Inc's market cap, and Alcon AG pays a 0.54% dividend while Commvault Systems Inc pays none. Which is the better fit depends on your goals.
| ALC | CVLT | |
|---|---|---|
Market Cap | $32.69B | $6.37B |
Sector | Health | Technology |
52-Week High | $92.22 | $195.41 |
52-Week Low | $62.02 | $75.18 |
Enterprise Value | $36.28B | $6.38B |
Dividend Yield | 0.54% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
Commvault Systems (CVLT) trades at $150.05, up 0.05% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $1.28 exceeding the $1.09 estimate. However, high valuation multiples like a P/E of 94.97 and P/B of 829.37 suggest premium pricing. Recent news highlights a class action lawsuit filed against the company, alongside positive product announcements including a #1 ranking in Gartner's 2026 backup solutions report.
Outlook remains mixed with analyst consensus leaning bullish (54.55% buy ratings) and a $128.75 price target below current levels. Key risks include the ongoing securities litigation and elevated valuations, while opportunities lie in continued earnings momentum and market leadership in data protection. Investors should weigh legal overhangs against fundamental strength.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About Commvault Systems Inc
Commvault provides enterprise-grade data protection and information management software. Its platform helps businesses manage, back up, and recover data across on-premises, cloud, and hybrid environments.
Read more on CVLT →
